170 related articles for article (PubMed ID: 34390800)
1. Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas.
Fordham AM; Ekert PG; Fleuren EDG
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188613. PubMed ID: 34390800
[TBL] [Abstract][Full Text] [Related]
2. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
3. Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine.
Wu X; Xing X; Dowlut D; Zeng Y; Liu J; Liu X
J Proteomics; 2019 Jan; 191():68-79. PubMed ID: 29621648
[TBL] [Abstract][Full Text] [Related]
4. Personalization of prostate cancer therapy through phosphoproteomics.
Yang W; Freeman MR; Kyprianou N
Nat Rev Urol; 2018 Aug; 15(8):483-497. PubMed ID: 29752463
[TBL] [Abstract][Full Text] [Related]
5. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
6. The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine.
Doll S; Gnad F; Mann M
Proteomics Clin Appl; 2019 Mar; 13(2):e1800113. PubMed ID: 30790462
[TBL] [Abstract][Full Text] [Related]
7. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
[TBL] [Abstract][Full Text] [Related]
8. Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderly.
Subbiah V
Curr Oncol Rep; 2014 Sep; 16(9):401. PubMed ID: 25030655
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of sarcomas: new vistas for precision medicine.
Al-Zaid T; Wang WL; Somaiah N; Lazar AJ
Virchows Arch; 2017 Aug; 471(2):243-255. PubMed ID: 28664413
[TBL] [Abstract][Full Text] [Related]
10. Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.
Hingorani P; Janeway K; Crompton BD; Kadoch C; Mackall CL; Khan J; Shern JF; Schiffman J; Mirabello L; Savage SA; Ladanyi M; Meltzer P; Bult CJ; Adamson PC; Lupo PJ; Mody R; DuBois SG; Parsons DW; Khanna C; Lau C; Hawkins DS; Randall RL; Smith M; Sorensen PH; Plon SE; Skapek SX; Lessnick S; Gorlick R; Reed DR
Cancer Genet; 2016 May; 209(5):182-94. PubMed ID: 27132463
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based interrogation of the kinome and its implications for precision oncology.
Lim Kam Sian TCC; Chüeh AC; Daly RJ
Proteomics; 2021 Sep; 21(17-18):e2000161. PubMed ID: 33547865
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid sarcoma as the prototype for personalized therapy in soft tissue sarcoma.
Assi T; Rassy E; Nassereddine H; Farhat F; Kattan J
Per Med; 2020 Jul; 17(4):241-244. PubMed ID: 32589100
[No Abstract] [Full Text] [Related]
13. Phosphoproteomics in translational research: a sarcoma perspective.
Noujaim J; Payne LS; Judson I; Jones RL; Huang PH
Ann Oncol; 2016 May; 27(5):787-94. PubMed ID: 26802162
[TBL] [Abstract][Full Text] [Related]
14. New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.
Lim J; Poulin NM; Nielsen TO
Clin Cancer Res; 2015 Nov; 21(21):4753-9. PubMed ID: 26330427
[TBL] [Abstract][Full Text] [Related]
15. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract][Full Text] [Related]
16. Implementation of Clinical Phosphoproteomics and Proteomics for Personalized Medicine.
Casado P; Hijazi M; Gerdes H; Cutillas PR
Methods Mol Biol; 2022; 2420():87-106. PubMed ID: 34905168
[TBL] [Abstract][Full Text] [Related]
17. Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics.
Lee CY; The M; Meng C; Bayer FP; Putzker K; Müller J; Streubel J; Woortman J; Sakhteman A; Resch M; Schneider A; Wilhelm S; Kuster B
Mol Syst Biol; 2024 Jan; 20(1):28-55. PubMed ID: 38177929
[TBL] [Abstract][Full Text] [Related]
18. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
[TBL] [Abstract][Full Text] [Related]
19. Not your average joint: Towards precision medicine in psoriatic arthritis.
Castillo R; Scher JU
Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
[TBL] [Abstract][Full Text] [Related]
20. Omics sciences and precision medicine in sarcoma.
Bonetti G; Donato K; Dhuli K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Cavalca D; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):68-76. PubMed ID: 37994750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
